Lysophosphatidylserine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lysophosphatidylserine" in English language version.

refsWebsite
Global rank English rank
2nd place
2nd place
4th place
4th place
102nd place
76th place

doi.org

  • van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, et al. (2002). "A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization". J Biol Chem. 277 (50): 48122–9. doi:10.1074/jbc.M206941200. hdl:1887/49917. PMID 12359728.
  • Shinjo Y, Makide K, Satoh K, Fukami F, Inoue A, Kano K, et al. (2017). "Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3/GPR174". Biochem Biophys Res Commun. 494 (1–2): 332–338. doi:10.1016/j.bbrc.2017.10.028. PMID 29017923.
  • Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, et al. (2006). "Identification of a lysophosphatidylserine receptor on mast cells". Biochem Biophys Res Commun. 341 (4): 1078–87. doi:10.1016/j.bbrc.2006.01.069. PMID 16460680.
  • Park KS, Lee HY, Kim MK, Shin EH, Bae YS (Jul 2005). "Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes". Biochemical and Biophysical Research Communications. 333 (2): 353–8. doi:10.1016/j.bbrc.2005.05.109. PMID 15946646.
  • Yea K, Kim J, Lim S, Kwon T, Park HS, Park KS, Suh PG, Ryu SH (Jan 2009). "Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes". Biochemical and Biophysical Research Communications. 378 (4): 783–8. doi:10.1016/j.bbrc.2008.11.122. PMID 19063864.

handle.net

hdl.handle.net

  • van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, et al. (2002). "A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization". J Biol Chem. 277 (50): 48122–9. doi:10.1074/jbc.M206941200. hdl:1887/49917. PMID 12359728.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, et al. (2002). "A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization". J Biol Chem. 277 (50): 48122–9. doi:10.1074/jbc.M206941200. hdl:1887/49917. PMID 12359728.
  • Shinjo Y, Makide K, Satoh K, Fukami F, Inoue A, Kano K, et al. (2017). "Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3/GPR174". Biochem Biophys Res Commun. 494 (1–2): 332–338. doi:10.1016/j.bbrc.2017.10.028. PMID 29017923.
  • Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, et al. (2006). "Identification of a lysophosphatidylserine receptor on mast cells". Biochem Biophys Res Commun. 341 (4): 1078–87. doi:10.1016/j.bbrc.2006.01.069. PMID 16460680.
  • Park KS, Lee HY, Kim MK, Shin EH, Bae YS (Jul 2005). "Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes". Biochemical and Biophysical Research Communications. 333 (2): 353–8. doi:10.1016/j.bbrc.2005.05.109. PMID 15946646.
  • Yea K, Kim J, Lim S, Kwon T, Park HS, Park KS, Suh PG, Ryu SH (Jan 2009). "Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes". Biochemical and Biophysical Research Communications. 378 (4): 783–8. doi:10.1016/j.bbrc.2008.11.122. PMID 19063864.